Area of research
Hematology · Oncology
Research interest
Research interests include Multiple Myeloma Research and Treatments, CAR-T cell therapy research, Protein Degradation and Inhibitors, and Cancer Treatment and Pharmacology.
Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study
Impact of second primary malignancy post–autologous transplantation on outcomes of multiple myeloma: a CIBMTR analysis
Adverse Event Reporting in Randomized Clinical Trials for Multiple Myeloma
Is aggressive treatment of smoldering myeloma the path to curing myeloma?
Characterizing the role of the immune microenvironment in multiple myeloma progression at a single-cell level
Time‐to‐event surrogate end‐points in multiple myeloma randomised trials from 2005 to 2019: A surrogacy analysis
Global Myeloma Trial Participation and Drug Access in the Era of Novel Therapies
Participation of Black Americans in Cancer Clinical Trials: Current Challenges and Proposed Solutions
Assessment and reporting of quality-of-life measures in pivotal clinical trials of hematological malignancies